Huawei Unveils the HUAWEI P20 and HUAWEI P20 Pro, Breakthroughs in Technology and Art to Redefine Intelligent Photography
Today Huawei Consumer Business Group unveiled the HUAWEI P20 Series. The HUAWEI P20 Pro features the world’s first Leica triple camera and both devices include unprecedented AI advances, combining technology and art to bring to life a groundbreaking smartphone experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180327005811/en/
Huawei Unveils the HUAWEI P20 and HUAWEI P20 Pro, Breakthroughs in Technology and Art to Redefine Intelligent Photography (Photo: Business Wire)
“We look for inspiration from artists to continuously evolve our approach to design and innovation,” said Richard Yu, Chief Executive Officer, Huawei Consumer Business Group. “With a breakthrough triple camera on the HUAWEI P20 Pro, an advanced dual camera on the HUAWEI P20 and powerful artificial intelligence on both, today’s most vibrant consumers can capture and share the brilliance of the world around them.”
Key features of the HUAWEI P20 Series include:
- An advanced camera to capture more light, featuring a Leica triple camera and 5x Hybrid Zoom on the HUAWEI P20 Pro, and a Leica dual camera on the HUAWEI P20, both achieving DxOMark’s highest overall scores1;
- Innovative photography features, including AI-powered professional photography features and HUAWEI AIS (AI Image Stabilization);
- A timeless design with barely-there bezels and all-new gradient colors;
- Ultimate performance, featuring the NPU on Kirin 970 and EMUI 8.1 based on Android™ 8.1.
A Combination of Art and Technology
The HUAWEI P20 Series comes in Black, Midnight Blue and two all-new gradient colors, Twilight and Pink Gold, achieved by applying several layers of NCVM* optical coatings underneath the glass back, so light hitting the surface refracts and creates a vivid, yet gradual change of hue.
The 5.8-inch screen HUAWEI P20 and 6.1-inch screen HUAWEI P20 Pro feature HUAWEI FullView Display, ultra-thin bezels and impressive screen-to-body ratios for better viewing experiences.
Inspired by Light and Technology
The HUAWEI P20 Pro features a Leica triple camera with the highest total pixel count on a smartphone – the camera configuration is comprised of a 40MP RGB sensor, a 20MP monochrome sensor and an 8MP sensor with telephoto lens. It also features an exclusive Leica color temperature sensor for better color reproduction. With f/1.8, f/1.6 and f/2.4 wide aperture to capture crisp, clear details, the HUAWEI P20 Pro also includes a brand new Leica 3x telephoto (VARIO-SUMMILUX-H 1:1.6-2.4/27-80ASPH) lens for long-range photography of up to 5x Hybrid Zoom. The HUAWEI P20 Pro’s highly sensitive image sensor captures low light photos with up to ISO 102400.
The HUAWEI P20 builds on its predecessor’s foundation with a Leica dual camera featuring a 12MP sensor with a pixel size as high as 1.55 μm, and a 20MP monochrome sensor, enhancing the HUAWEI P20’s ability to capture photos in low-light settings.
The HUAWEI P20 Series devices support six-axis stabilization and 960fps super slow motion. With Ultra Snapshot mode, the devices can capture an image in as little as 0.3 seconds by just double clicking the down volume button, even from an off screen.
Master AI Photography Experience
With the Kirin 970 processor, the HUAWEI P20 Series automatically identifies more than 500 scenarios in 19 categories, selecting camera settings to deliver professional-looking images. HUAWEI AIS steadies handheld night shots for incredible long exposure images without a tripod. Brand new to Huawei’s advanced camera system is 4D predictive focus, predicting moving objects and focusing on them with extreme efficiency to capture minute detail. The HUAWEI P20 Series also features AI-Assisted Composition, providing intelligent suggestions to frame group shots and landscapes.
The HUAWEI P20 and HUAWEI P20 Pro feature a 24MP selfie camera** with AI beautification and 3D portrait lighting. The HUAWEI P20 Series also includes on-device Prisma processing, which supports real-time filter recommendations based on scene and object recognition.
In partnership with Google, the HUAWEI P20 Series supports Google ARCore, delivering advanced AR capabilities.
Collaboration with Porsche Design
Huawei also unveiled the PORSCHE DESIGN HUAWEI Mate RS. Continuing its collaboration with the exclusive luxury brand, the PORSCHE DESIGN HUAWEI Mate RS features Porsche Design’s signature functional design language and Huawei’s cutting-edge technology and craftsmanship, setting a new standard in premium smartphones.
Pricing and Availability
The HUAWEI P20 Series and PORSCHE DESIGN HUAWEI Mate RS are immediately available globally.
|Model||Version||EUR (includes tax)|
|HUAWEI P20||4GB + 128GB||
|HUAWEI P20 Pro||6GB + 128GB||
|PORSCHE DESIGN HUAWEI Mate RS||6GB + 256GB||
|PORSCHE DESIGN HUAWEI Mate RS||6GB + 512GB||
*Non-conductive Vacuum Metalizing
For more information please visit: https://consumer.huawei.com/en/
1 Highest overall DxOMark scores in the mobile camera category – HUAWEI P20 Pro: 109; HUAWEI P20: 102.
Racepoint Global for Huawei Consumer BG
Lisa Kennedy, 1-415-694-6700
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 10:49 | Pressemelding
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41 | Pressemelding
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42 | Pressemelding
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00 | Pressemelding
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07 | Pressemelding
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha